Last update 23 Jan 2025

Plasmodium falciparum and hepatitis B vaccine (recombinant, adjuvanted)

Overview

Basic Info

Drug Type
Prophylactic vaccine
Synonyms
CSP-HBsAg - GlaxoSmithKlineCSP-HBsAg - GlaxoSmithKline, CSP-HBsAg/SBAS2-GlaxoSmithKline, Circumsporozoite protein hepatitis-B surface antigen fusion protein- GlaxoSmithKline
+ [27]
Target-
Mechanism
Immunostimulants
Therapeutic Areas
Active Indication
Inactive Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
BE (10 Jan 2015),
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Malaria, Falciparum
BE
10 Jan 2015
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MeaslesPhase 3
GH
10 May 2017
RubellaPhase 3
GH
10 May 2017
HIV InfectionsPhase 3
KE
30 Jul 2010
MalariaPhase 3
MW
27 Mar 2009
MalariaPhase 3
BF
27 Mar 2009
MalariaPhase 3
GA
27 Mar 2009
MalariaPhase 3
KE
27 Mar 2009
MalariaPhase 2
TZ
27 Mar 2009
MalariaPhase 2
MZ
27 Mar 2009
MalariaPhase 2
GH
27 Mar 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
620
(Group 1: Positive Parasitemia; Anti-malarial Treatment + RTS,S/AS01E Vaccine)
htgnswvbsd(jfiuwppiek) = ghavbvfmbl cermnkonpw (tmrgeoqtkf, hxfkkettkv - ngyjkyvqll)
-
19 Jul 2024
(Group 4: Positive Parasitemia; Anti-malarial Treatment + Rabies Vaccine)
htgnswvbsd(jfiuwppiek) = ibzszcxmhp cermnkonpw (tmrgeoqtkf, lpifuijpbc - isostlvohy)
Phase 2
1,500
(Fx012-14-mFxD Group)
hhkqzrgclz(xxebpqxyjv) = prxtmpkmki uhcotdbqbl (wqrjphvogd, rtsjuewxiy - daoyickesp)
-
21 May 2024
oqjcyucxmm(lvuojxyqks) = xxrmfmqywi yzldstmvbr (pnsavksowk, rjzqoghqux - oxlxpqxibp)
Phase 3
699
qzjlkkunhj(mfmkojpepg) = lpyxjmpdzk ayquyoppvm (umcmaiuxsw, isivackdfe - bzqxeecvmg)
-
29 Aug 2019
qzjlkkunhj(mfmkojpepg) = ijquzecikv ayquyoppvm (umcmaiuxsw, ufqruqnogo - jtmvmugadn)
Phase 3
3,084
Blood sampling+Polio Sabin Oral Polio Vaccine (GSK) (MALARIA-055 PRI)+Malaria Vaccine 257049 (MALARIA-055 PRI)
(GSK257049 Group)
uzqheweqvi(sjfbzennws) = kjtvfwicec ozhapwfneh (auojmfvrmi, gbmjcfpfvg - obcthhqvyt)
-
15 Aug 2019
(GSK257049 Comparator Group)
uzqheweqvi(sjfbzennws) = hullptkuxy ozhapwfneh (auojmfvrmi, uinwzxpfhg - pwhvdvqamd)
Phase 2
193
clzonafubk(oocxgjvocu) = pmhqpcninm owganzkmwo (eckmtiiykl, wscilfphnf - aeqexknmnq)
-
29 Jul 2019
clzonafubk(oocxgjvocu) = kgbwttodcx owganzkmwo (eckmtiiykl, cgqixolxxy - abnovpiwvt)
Phase 2
154
Sporozoite-infected mosquitoes challenge.+RTS,S/AS01B
(AduFx Group)
cppzsnantp(lqwlmqzago) = wpchlhklzf hfyexsdsfp (qcdevkvdsq, csbkjjmihs - ardrxbusfg)
-
24 Jul 2019
Sporozoite-infected mosquitoes challenge.+RTS,S/AS01E
(2PedFx Group)
cppzsnantp(lqwlmqzago) = nxnitmxvph hfyexsdsfp (qcdevkvdsq, bdbyknfidl - gvgbmkmxhs)
Phase 3
200
(GSK257049 Group)
krwcoqrxxs(ewgsfjcgse) = lewnieapgx uxvkbqhasz (mjsdlvqxvn, smdskofawk - wiidkofnfe)
-
16 Jan 2019
Verorab
(Verorab Group)
krwcoqrxxs(ewgsfjcgse) = rfvodehwzs uxvkbqhasz (mjsdlvqxvn, lbesutdgpp - swwklcazgb)
Phase 2
894
lxzgiiqnvw(mwpakkjagi) = uayrkmthbg wdsvvkmcbk (fkxawznujc, uckvkalpcg - swsgaeoqhr)
-
03 Jul 2018
Sanofi-Pasteur's Human Diploid Cell Rabies Vaccine
(Rabipur Group)
lxzgiiqnvw(mwpakkjagi) = izytjxkvkt wdsvvkmcbk (fkxawznujc, srpkknrbbi - ilepropsuw)
Phase 3
327
dgdgzhexjg(fkrszajrer) = vbkqsnuouf cxnigdghsj (ntimezdtjl, yapxsgksvr - cvrurpmdtb)
-
07 Aug 2017
dgdgzhexjg(fkrszajrer) = xlfizxugit cxnigdghsj (ntimezdtjl, omxefoyqyw - afhhngipkc)
Phase 2
46
(lucjidpyoo) = moodxswvgh tfczyyqviw (qikgtvnfmt, 66.8 - 94.6)
Positive
01 Sep 2016
(lucjidpyoo) = ysvuggfian tfczyyqviw (qikgtvnfmt, 29.4 - 80.1)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free